View Document Preview and Link Document Date: 2015-04-20 05:17:21 Open Document File Size: 338,44 KB Share Result on Facebook
City Geneva / Dakar / Cape Town / / Company ABC / Expert Advisory Group / MPP / / Country Ecuador / South Africa / Thailand / Indonesia / United States / Brazil / China / India / / Currency USD / / Event FDA Phase / Business Partnership / / Facility Pipeline HIV Medicines / stable FDCs / Pipeline Report / / IndustryTerm AIDS Treatment / age / bilateral technology transfer agreement / HIV Treatment / systematic search / priority product / active pharmaceutical ingredient / manufacturing base / generic manufacturing / priority products / manufacturing / / MedicalCondition TB / HIV / infections / Opportunistic Infections / malaria / Neglected Diseases / HIV/AIDS / viral hepatitis / tuberculosis / / Organization WHO Department of HIV/AIDS / World Health Organization / ETV / MPP Governance Board / Federal Trade Commission / United States Food and Drug Administration / Children’s Investment Fund Foundation / PADO / TDF / national patent office / / Position candidate for replacing current first-line recommendations / / Product Efavirenz / FDCs / Tenofovir disoproxil fumarate / 50mg / nevirapine / Abacavir / DRV oral / US / DTG / TAF / / PublishedMedium the WHO / / Region Sub-Saharan Africa / / Technology API / / SocialTag 
ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL